IP6K1 and neoplasm: FACS analyses revealed i) increased CD11b+Gr1 + IL10+ myeloid cells, ii) decreased anti-tumor, M1 TAMs, and iii) markedly reduced infiltration of dendritic cells into the tumor microenvironment in IP6K1 KO mice.